Trial Profile
Placebo-controlled, Double-blind, Randomized Study of Aerucin as Adjunct Therapy to Antibiotics in the Treatment of P. Aeruginosa Pneumonia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs AR 105 (Primary)
- Indications Pseudomonal infections; Ventilator associated pneumonia
- Focus Therapeutic Use
- Sponsors Aridis Pharmaceuticals
- 03 Sep 2019 Primary endpoint has not been met. (Clinical Cure: treatment success, treatment failure)
- 03 Sep 2019 Results published in the Media Release
- 08 Aug 2019 Status changed from active, no longer recruiting to completed.